RANIERI, BRIGIDA
 Distribuzione geografica
Continente #
NA - Nord America 803
EU - Europa 449
AS - Asia 220
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.477
Nazione #
US - Stati Uniti d'America 797
IT - Italia 131
CN - Cina 85
VN - Vietnam 78
UA - Ucraina 64
DE - Germania 57
SE - Svezia 48
SG - Singapore 43
RU - Federazione Russa 40
IE - Irlanda 36
FI - Finlandia 27
GB - Regno Unito 16
FR - Francia 14
MT - Malta 5
BR - Brasile 4
KR - Corea 4
JP - Giappone 3
MX - Messico 3
TR - Turchia 3
CA - Canada 2
CZ - Repubblica Ceca 2
GR - Grecia 2
RO - Romania 2
AT - Austria 1
BE - Belgio 1
BG - Bulgaria 1
CR - Costa Rica 1
ES - Italia 1
EU - Europa 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
NL - Olanda 1
PH - Filippine 1
Totale 1.477
Città #
Chandler 100
Dong Ket 78
Jacksonville 74
Fairfield 58
Dearborn 44
New York 40
Ashburn 39
Singapore 36
Dublin 34
Woodbridge 31
Pescara 30
Wilmington 27
Helsinki 25
Seattle 22
Houston 21
Falkenstein 20
Lawrence 20
Princeton 20
Ann Arbor 19
L'aquila 18
Cambridge 17
Moscow 15
Shanghai 15
Boardman 14
Nanjing 14
Bojano 13
Beijing 11
Des Moines 9
Rome 8
Città Sant'Angelo 7
Monteroni D'arbia 7
Corby 6
Bellante 5
Forcoli 5
Nanchang 5
Guangzhou 4
Kunming 4
Munich 4
Redwood City 4
Attard 3
Curitiba 3
Hangzhou 3
Hefei 3
Los Angeles 3
Antalya 2
Aquila 2
Athens 2
Birkirkara 2
Buffalo 2
Fuzhou 2
Lanzhou 2
Lappeenranta 2
Mexico 2
Mount Pleasant 2
Ottawa 2
Paris 2
Pontedera 2
San Diego 2
Tokyo 2
Amman 1
Bantice 1
Baotou 1
Bari 1
Bethesda 1
Bishkek 1
Bloomington 1
Brno 1
Brussels 1
Chengdu 1
Dortmund 1
Essen 1
Francavilla al Mare 1
Greenock 1
Hebei 1
Istanbul 1
Jinan 1
Jinhua 1
Lynnwood 1
Mashhad 1
Mason 1
Murcia 1
Norwalk 1
Rio de Janeiro 1
San Benedetto del Tronto 1
San José 1
Seoul 1
Shenyang 1
Shizuoka 1
Sofia 1
Swansea 1
Taiyuan 1
Taizhou 1
Tianjin 1
Turin 1
Vienna 1
Vittuone 1
Wuhan 1
Yinchuan 1
Zhengzhou 1
Totale 1.008
Nome #
Targeted therapy of human glioblastoma via delivery of a toxin through a peptide directed to cell surface nucleolin 195
Effects of Substantia Nigra pars compacta lesion on the behavioral sequencing in the 6-OHDA model of Parkinson's disease 130
A Validation Study of TrAQ: a Versatile and Automated Behavioural Analysis Software 117
Comparison between Tail Suspension Swing Test and Standard Rotation Test in Revealing Early Motor Behavioral Changes and Neurodegeneration in 6-OHDA Hemiparkinsonian Rats 81
Apomorphine-Induced Behavioural Changes in an Early-Stage of the 6-OHDA Hemiparkinsonian Rat Model 79
A behavioural and MRI structural study of early stage 6-OHDA Parkinson's disease rat model 78
Early Apo Treatment effects on BG motor control disruption: implication for entropy-based PD kinematics 75
The Tail Suspension Swing Test (TSST), a novel drug-free method for assessing earlier motor and functional asymmetry in 6-OHDA hemiparkinsonian rats 73
A semi-automatic user-friendly tracking software (TrAQ) for animal models capable of automatic turning rotation behaviour characterization 72
MRI characterization of structural modifications in Striatum of Parkinson’s disease rat model 69
Magnetic Resonance Imaging characterization of early PD development 64
Evaluation of functional asymmetry in hemiparkinsonian rats using a modified Tail Suspension Test 55
The Tail Suspension Test as an easy model for assessing the functional asymmetry of hemiparkinsonian rats 55
A novel, versatile and automated tracking software (TrAQ) for the characterization of rodent behaviour 55
The time course of striatal T1 changes in the 6-OHDA hemiparkinsonian rat model correlates with the tail suspension swing test 54
Striatal T1 Increase Correlates with Early-Phase Nigral Degeneration in the 6-OHDA Hemiparkinsonian Rat Model 54
A novel versatile and automated tracking software (TrAQ) for the characterization of behavioural rodent models 52
Evaluation of functional asymmetry in hemiparkinsonian rats using a modified tail suspension test 51
TrAQ: a versatile and automated tracking software for the characterization of behavioural rodent models 50
Motor and structural asymmetries: biomarkers in early-phase Parkinson’s disease characterization 44
Totale 1.503
Categoria #
all - tutte 7.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.484


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020150 0 0 0 0 0 40 41 27 13 16 3 10
2020/2021272 8 11 8 20 4 35 4 34 30 6 27 85
2021/2022234 1 21 8 30 22 9 1 17 11 2 99 13
2022/2023290 45 1 3 14 36 50 1 42 61 12 22 3
2023/2024152 10 46 9 6 0 43 1 19 0 1 3 14
2024/2025180 10 22 38 39 7 64 0 0 0 0 0 0
Totale 1.503